Copyright © 2000 by the European Society of Cardiology.
Editorial
C-reactive protein in healthy and in sick populations
a Clinical Trial Service Unit and Epidemiological Studies Unit, Nuffield Department of Clinical Medicine, University of Oxford, Radcliffe Infirmary, Oxford, U.K.
b Department of Medicine, Royal Free Hospital and University College MedicalSchool, London, U.K.
References
- Pepys MB. The acute phase response and C-reactive protein. Weatherall DJ, Ledingham JCG, Warrell DA. Oxford Textbook of Medicine. Oxford: Oxford University Press; 1995.
- Danesh J, Collins R, Appleby P, Peto R. Fibrinogen, C-reactive protein, albumin or white cell count: meta-analyses of prospective studies of coronary heart disease. JAMA. 1998;279:14771482
[Abstract/Free Full Text] - Ridker PM, Rifai N, Pfeffer MA, Sacks FM, Braunwald E. Long-term effects of pravastatin on plasma concentration of C-reactive protein. Circulation. 1999;100:230235
[Abstract/Free Full Text] - Danesh J, Whincup PH, Walker M. Low-grade inflammation and coronary heart disease: new prospective studies and updated meta-analyses. BMJ. 2000;:
- Lagrand WK, Visser CA, Hermens W. C-reactive protein as a cardiovascular risk factor: more than an epiphenomenon? Circulation. 1999;100:96102
[Abstract/Free Full Text] - Danesh J, Muir J, Wong Y-K, Ward M, Gallimore R, Pepys MB. Risk factors for coronary heart disease and acute-phase proteins: population-based study. Eur Heart J. 1999;20:954959
[Abstract/Free Full Text] - Danesh J, Collins R, Peto R. Chronic infections and coronary heart disease: is there a link? Lancet. 1997;350:430436[CrossRef][ISI][Medline]
- Ross R. Atherosclerosisan inflammatory disease. N Engl J Med. 1999;340:115121
[Free Full Text] - Muir KW, Weir CJ, Alwan W, Squire IB, Lees KR. C-reactive protein and outcome after ischemic stroke. Stroke. 1999;30:985
- Jager A, van Hinsbergh VWM, Kostense PJ. von Willebrand factor, C-reactive protein, and 5-year mortality in diabetic and nondiabetic subjects. Arteroscler Thromb Vasc Biol. 1999;19:3078
- Iseki K, Tozawa M, Yoshi S, Fukiyama K. Serum CRP (C-reactive protein) and risk of death in chronic dialysis patients. Nephrol Dial Transplant. 1999;14:19561960
[Abstract/Free Full Text] - Clarke R, Shipley M, Lewington S. Underestimation of risk associations due to regression dilution in long-term follow-up of prospective studies. Am J Epidemiol. 1999;150:341353
[Abstract/Free Full Text] - Garcia-Moll X, Zouridakis E, Cole D, Kaski JC. C-reactive protein in patients with chronic stable angina: differences in baseline serum concentration between women and men. Eur Heart J. 2000;21:15981606
[Abstract/Free Full Text] - Cushman M, Legault C, Barrett-Connor EL. Effect of postmenopausal hormones on inflammation-sensitive proteins: the Postmenopausal Estrogen/Progestin Interventions (PEPI) study. Circulation. 1999;100:717722
[Abstract/Free Full Text] - Hutchinson WL, Koenig W, Frohlich M, Sund M, Lowe GDO, Pepys MB. Immunoradiometric assay of circulating C-reactive protein: age-related values in the adult general population. Clin Chem. 2000;:
- Ford ES. Body mass index, diabetes, and C-reactive protein among U.S. adults. Diabetes Care. 1999;22:19711979
[Abstract/Free Full Text]
This article has been cited by other articles:
![]() |
C. Siemes, L. E. Visser, J.-W. W. Coebergh, T. A.W. Splinter, J. C.M. Witteman, A. G. Uitterlinden, A. Hofman, H. A.P. Pols, and B. H.Ch. Stricker C-Reactive Protein Levels, Variation in the C-Reactive Protein Gene, and Cancer Risk: The Rotterdam Study J. Clin. Oncol., November 20, 2006; 24(33): 5216 - 5222. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Kholeif C-Reactive Protein for Cardiovascular Risk Assessment Diabetes Care, July 1, 2005; 28(7): 1833 - 1834. [Full Text] [PDF] |
||||
![]() |
M. Di Napoli, M. Schwaninger, R. Cappelli, E. Ceccarelli, G. Di Gianfilippo, C. Donati, H. C.A. Emsley, S. Forconi, S. J. Hopkins, L. Masotti, et al. Evaluation of C-Reactive Protein Measurement for Assessing the Risk and Prognosis in Ischemic Stroke: A Statement for Health Care Professionals From the CRP Pooling Project Members Stroke, June 1, 2005; 36(6): 1316 - 1329. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Sanchez-Moreno, M. P. Cano, B. de Ancos, L. Plaza, B. Olmedilla, F. Granado, and A. Martin High-Pressurized Orange Juice Consumption Affects Plasma Vitamin C, Antioxidative Status and Inflammatory Markers in Healthy Humans J. Nutr., July 1, 2003; 133(7): 2204 - 2209. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||



